STERIS plc (STE)
USD 207.01
(-1.19%)
USD 207.01
(-1.19%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 2.23 Billion USD | 2.71% |
| 2023 | 2.15 Billion USD | 7.11% |
| 2022 | 2.01 Billion USD | 50.13% |
| 2021 | 1.34 Billion USD | 1.76% |
| 2020 | 1.31 Billion USD | 12.29% |
| 2019 | 1.17 Billion USD | 7.42% |
| 2018 | 1.09 Billion USD | 6.69% |
| 2017 | 1.02 Billion USD | 14.53% |
| 2016 | 895.48 Million USD | 15.65% |
| 2015 | 774.3 Million USD | 19.19% |
| 2014 | 649.62 Million USD | 4.56% |
| 2013 | 621.26 Million USD | 9.29% |
| 2012 | 568.46 Million USD | 27.41% |
| 2011 | 446.16 Million USD | -17.25% |
| 2010 | 539.18 Million USD | 2.36% |
| 2009 | 526.74 Million USD | 0.53% |
| 2008 | 523.95 Million USD | 3.79% |
| 2007 | 504.8 Million USD | 4.26% |
| 2006 | 484.18 Million USD | 2.66% |
| 2005 | 471.65 Million USD | 3.0% |
| 2004 | 457.89 Million USD | 12.0% |
| 2003 | 408.82 Million USD | 15.1% |
| 2002 | 355.2 Million USD | -5.16% |
| 2001 | 374.51 Million USD | 5.47% |
| 2000 | 355.09 Million USD | -11.65% |
| 1999 | 401.9 Million USD | 23.83% |
| 1998 | 324.55 Million USD | 30.66% |
| 1997 | 248.4 Million USD | 320.3% |
| 1996 | 59.1 Million USD | 42.07% |
| 1995 | 41.6 Million USD | 45.45% |
| 1994 | 28.6 Million USD | 78.75% |
| 1993 | 16 Million USD | 119.18% |
| 1992 | 7.3 Million USD | 35.19% |
| 1991 | 5.4 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 593.52 Million USD | 3.5% |
| 2024 FY | 2.23 Billion USD | 3.44% |
| 2024 Q3 | 602.59 Million USD | 1.53% |
| 2024 Q4 | 650.66 Million USD | 7.98% |
| 2024 Q1 | 573.46 Million USD | -2.48% |
| 2023 FY | 2.15 Billion USD | 7.11% |
| 2023 Q2 | 532.33 Million USD | 2.81% |
| 2023 Q1 | 517.79 Million USD | -9.42% |
| 2023 Q3 | 521.49 Million USD | -2.04% |
| 2023 Q4 | 588.06 Million USD | 12.76% |
| 2022 Q1 | 426.28 Million USD | 12.23% |
| 2022 FY | 2.01 Billion USD | 50.13% |
| 2022 Q2 | 480.34 Million USD | 12.68% |
| 2022 Q3 | 538.11 Million USD | 12.03% |
| 2022 Q4 | 571.62 Million USD | 6.23% |
| 2021 FY | 1.34 Billion USD | 1.76% |
| 2021 Q4 | 379.81 Million USD | 9.82% |
| 2021 Q1 | 285.56 Million USD | -21.56% |
| 2021 Q3 | 345.86 Million USD | 4.79% |
| 2021 Q2 | 330.03 Million USD | 15.57% |
| 2020 FY | 1.31 Billion USD | 12.29% |
| 2020 Q2 | 318.66 Million USD | 4.19% |
| 2020 Q3 | 331.35 Million USD | 3.98% |
| 2020 Q4 | 364.06 Million USD | 9.87% |
| 2020 Q1 | 305.84 Million USD | -8.63% |
| 2019 Q4 | 334.71 Million USD | 16.63% |
| 2019 Q3 | 286.99 Million USD | 0.82% |
| 2019 Q2 | 284.66 Million USD | 5.8% |
| 2019 FY | 1.17 Billion USD | 7.42% |
| 2019 Q1 | 269.05 Million USD | -8.1% |
| 2018 Q4 | 292.75 Million USD | 5.08% |
| 2018 FY | 1.09 Billion USD | 6.69% |
| 2018 Q3 | 278.58 Million USD | 4.43% |
| 2018 Q2 | 266.76 Million USD | 4.15% |
| 2018 Q1 | 256.12 Million USD | -8.57% |
| 2017 Q3 | 257.6 Million USD | 3.91% |
| 2017 FY | 1.02 Billion USD | 14.53% |
| 2017 Q1 | 239.99 Million USD | -9.06% |
| 2017 Q2 | 247.9 Million USD | 3.3% |
| 2017 Q4 | 280.12 Million USD | 8.74% |
| 2016 Q1 | 184.09 Million USD | -13.6% |
| 2016 Q2 | 209.32 Million USD | 13.71% |
| 2016 Q3 | 238.18 Million USD | 13.79% |
| 2016 Q4 | 263.88 Million USD | 10.79% |
| 2016 FY | 895.48 Million USD | 15.65% |
| 2015 FY | 774.3 Million USD | 19.19% |
| 2015 Q2 | 193.99 Million USD | 14.05% |
| 2015 Q1 | 170.09 Million USD | -7.81% |
| 2015 Q3 | 197.15 Million USD | 1.63% |
| 2015 Q4 | 213.06 Million USD | 8.07% |
| 2014 Q3 | 163.77 Million USD | 6.0% |
| 2014 Q4 | 184.49 Million USD | 12.65% |
| 2014 FY | 649.62 Million USD | 4.56% |
| 2014 Q1 | 146.84 Million USD | -17.39% |
| 2014 Q2 | 154.5 Million USD | 5.22% |
| 2013 Q3 | 153.12 Million USD | 0.0% |
| 2013 Q4 | 177.76 Million USD | 16.1% |
| 2013 FY | 621.26 Million USD | 9.29% |
| 2013 Q1 | 137.25 Million USD | -16.42% |
| 2013 Q2 | 153.12 Million USD | 11.56% |
| 2012 Q4 | 164.22 Million USD | 19.0% |
| 2012 Q1 | 132.92 Million USD | -14.81% |
| 2012 Q3 | 138 Million USD | 3.52% |
| 2012 FY | 568.46 Million USD | 27.41% |
| 2012 Q2 | 133.3 Million USD | 0.29% |
| 2011 Q4 | 156.02 Million USD | 13.88% |
| 2011 Q1 | 18.06 Million USD | -87.3% |
| 2011 Q2 | 135.05 Million USD | 647.56% |
| 2011 Q3 | 137.01 Million USD | 1.45% |
| 2011 FY | 446.16 Million USD | -17.25% |
| 2010 Q3 | 139.48 Million USD | 5.15% |
| 2010 FY | 539.18 Million USD | 2.36% |
| 2010 Q2 | 132.65 Million USD | 6.26% |
| 2010 Q4 | 142.2 Million USD | 1.95% |
| 2010 Q1 | 124.83 Million USD | -10.71% |
| 2009 FY | 526.74 Million USD | 0.53% |
| 2009 Q1 | 130.5 Million USD | -13.79% |
| 2009 Q4 | 139.81 Million USD | 12.69% |
| 2009 Q3 | 124.06 Million USD | -6.27% |
| 2009 Q2 | 132.36 Million USD | 1.43% |
| 2008 Q4 | 151.37 Million USD | 16.27% |
| 2008 FY | 523.95 Million USD | 3.79% |
| 2008 Q2 | 123.67 Million USD | 4.18% |
| 2008 Q1 | 118.71 Million USD | -18.11% |
| 2008 Q3 | 130.19 Million USD | 5.28% |
| 2007 Q2 | 118.76 Million USD | 4.75% |
| 2007 Q3 | 127.7 Million USD | 7.53% |
| 2007 Q4 | 144.97 Million USD | 13.52% |
| 2007 FY | 504.8 Million USD | 4.26% |
| 2007 Q1 | 113.37 Million USD | -14.97% |
| 2006 Q4 | 133.33 Million USD | 9.2% |
| 2006 Q2 | 116.23 Million USD | -1.31% |
| 2006 Q1 | 117.77 Million USD | -9.9% |
| 2006 Q3 | 122.09 Million USD | 5.04% |
| 2006 FY | 484.18 Million USD | 2.66% |
| 2005 Q2 | 111.48 Million USD | 1.45% |
| 2005 Q3 | 119.56 Million USD | 7.24% |
| 2005 FY | 471.65 Million USD | 3.0% |
| 2005 Q4 | 130.7 Million USD | 9.32% |
| 2005 Q1 | 109.89 Million USD | -12.52% |
| 2004 Q1 | 106.57 Million USD | -8.65% |
| 2004 Q3 | 115.09 Million USD | 4.05% |
| 2004 Q2 | 110.61 Million USD | 3.79% |
| 2004 Q4 | 125.61 Million USD | 9.14% |
| 2004 FY | 457.89 Million USD | 12.0% |
| 2003 Q2 | 96.39 Million USD | 4.99% |
| 2003 Q3 | 103.94 Million USD | 7.83% |
| 2003 FY | 408.82 Million USD | 15.1% |
| 2003 Q1 | 91.81 Million USD | -8.61% |
| 2003 Q4 | 116.66 Million USD | 12.24% |
| 2002 Q3 | 88.84 Million USD | 4.93% |
| 2002 Q1 | 81.21 Million USD | -6.32% |
| 2002 FY | 355.2 Million USD | -5.16% |
| 2002 Q4 | 100.46 Million USD | 13.08% |
| 2002 Q2 | 84.67 Million USD | 4.26% |
| 2001 Q2 | 96.32 Million USD | 7.96% |
| 2001 FY | 374.51 Million USD | 5.47% |
| 2001 Q4 | 86.69 Million USD | -15.24% |
| 2001 Q1 | 89.22 Million USD | 36.64% |
| 2001 Q3 | 102.27 Million USD | 6.18% |
| 2000 Q4 | 65.29 Million USD | -32.82% |
| 2000 FY | 355.09 Million USD | -11.65% |
| 2000 Q3 | 97.2 Million USD | -3.48% |
| 2000 Q2 | 100.7 Million USD | 9.58% |
| 2000 Q1 | 91.9 Million USD | -17.65% |
| 1999 Q4 | 111.6 Million USD | 7.1% |
| 1999 FY | 401.9 Million USD | 23.83% |
| 1999 Q1 | 81.31 Million USD | -14.84% |
| 1999 Q2 | 97.6 Million USD | 20.03% |
| 1999 Q3 | 104.2 Million USD | 6.76% |
| 1998 Q3 | 84.04 Million USD | 7.5% |
| 1998 FY | 324.55 Million USD | 30.66% |
| 1998 Q1 | 66.83 Million USD | -13.32% |
| 1998 Q2 | 78.18 Million USD | 16.99% |
| 1998 Q4 | 95.48 Million USD | 13.61% |
| 1997 Q3 | 63.5 Million USD | 11.8% |
| 1997 Q1 | 51 Million USD | 203.57% |
| 1997 FY | 248.4 Million USD | 320.3% |
| 1997 Q4 | 77.1 Million USD | 21.42% |
| 1997 Q2 | 56.8 Million USD | 11.37% |
| 1996 Q2 | 13.8 Million USD | 7.81% |
| 1996 FY | 59.1 Million USD | 42.07% |
| 1996 Q4 | 16.8 Million USD | 7.69% |
| 1996 Q3 | 15.6 Million USD | 13.04% |
| 1996 Q1 | 12.8 Million USD | 0.79% |
| 1995 Q2 | 9.7 Million USD | 15.48% |
| 1995 Q3 | 10.7 Million USD | 10.31% |
| 1995 Q4 | 12.7 Million USD | 18.69% |
| 1995 FY | 41.6 Million USD | 45.45% |
| 1995 Q1 | 8.4 Million USD | -7.69% |
| 1994 Q2 | 6.4 Million USD | 16.36% |
| 1994 Q4 | 9.1 Million USD | 19.74% |
| 1994 Q3 | 7.6 Million USD | 18.75% |
| 1994 Q1 | 5.5 Million USD | 1.85% |
| 1994 FY | 28.6 Million USD | 78.75% |
| 1993 Q1 | 3 Million USD | -36.17% |
| 1993 FY | 16 Million USD | 119.18% |
| 1993 Q2 | 3.6 Million USD | 20.0% |
| 1993 Q3 | 4.1 Million USD | 13.89% |
| 1993 Q4 | 5.4 Million USD | 31.71% |
| 1992 Q2 | 2.5 Million USD | -26.47% |
| 1992 Q4 | 4.7 Million USD | 38.24% |
| 1992 FY | 7.3 Million USD | 35.19% |
| 1992 Q1 | 3.4 Million USD | 54.55% |
| 1992 Q3 | 3.4 Million USD | 36.0% |
| 1991 FY | 5.4 Million USD | 0.0% |
| 1991 Q3 | 2.5 Million USD | 4.17% |
| 1991 Q1 | 2.5 Million USD | 0.0% |
| 1991 Q2 | 2.4 Million USD | -4.0% |
| 1991 Q4 | 2.2 Million USD | -12.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Abbott Laboratories | 22.13 Billion USD | 89.907% |
| Allurion Technologies Inc. | 41.49 Million USD | -5283.512% |
| Artivion, Inc. | 229.17 Million USD | -874.795% |
| Avanos Medical, Inc. | 379.7 Million USD | -488.358% |
| Butterfly Network, Inc. | 16.85 Million USD | -13153.417% |
| Butterfly Network, Inc. | 16.85 Million USD | -13153.417% |
| Bio-Rad Laboratories, Inc. | 1.43 Billion USD | -56.077% |
| Boston Scientific Corporation | 9.89 Billion USD | 77.423% |
| Perspective Therapeutics, Inc. | 1.63 Million USD | -136619.461% |
| CONMED Corporation | 643.06 Million USD | -247.397% |
| Edwards Lifesciences Corporation | 4.62 Billion USD | 51.697% |
| Paragon 28, Inc. | 172.79 Million USD | -1192.889% |
| Glaukos Corporation | 239.13 Million USD | -834.195% |
| Globus Medical, Inc. | 1.02 Billion USD | -118.954% |
| Inspire Medical Systems, Inc. | 528.22 Million USD | -322.927% |
| Integer Holdings Corporation | 418.28 Million USD | -434.08% |
| Medtronic plc | 19.45 Billion USD | 88.516% |
| Nevro Corp. | 290.06 Million USD | -670.184% |
| Owlet, Inc. | 22.58 Million USD | -9790.627% |
| Penumbra, Inc. | 682.64 Million USD | -227.257% |
| Vicarious Surgical Inc. | -1.85 Million USD | 120596.009% |
| Smith & Nephew plc | 3.7 Billion USD | 39.638% |
| Sonendo, Inc. | 10.72 Million USD | -20735.628% |
| Stryker Corporation | 13.05 Billion USD | 82.892% |
| Vapotherm, Inc. | 28.28 Million USD | -7798.724% |
| Zimmer Biomet Holdings, Inc. | 5.31 Billion USD | 57.932% |